INFLIXIMAB
Manner of administration:Injection
Restriction (Streamlined authority code: 9632)
Indication: Acute severe ulcerative colitis
Manner of administration:Injection
Restriction (Streamlined authority code: 4524)
Indication: Acute severe ulcerative colitis
Manner of administration:Injection
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 1 (new patient)
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break
in biological medicine of less than 5 years)
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 3 (recommencement of treatment after a break in biological
medicine of more than 5 years)
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Balance of supply
Manner of administration:Injection
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 1 (new patient)
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break
in biological medicine of less than 5 years)
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial treatment - Initial 3 (recommencement of treatment after a break in biological
medicine of more than 5 years)
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Balance of supply
Manner of administration:Injection
Restriction
Indication: Severe Crohn disease
Treatment phase: Subsequent continuing treatment
Manner of administration:Injection
Restriction (Streamlined authority code: 18868)
Indication: Severe Crohn disease
Treatment phase: Continuing treatment
Manner of administration:Injection
Restriction
Indication: Severe Crohn disease
Treatment phase: Subsequent continuing treatment
Manner of administration:Injection
Restriction (Streamlined authority code: 18819)
Indication: Severe Crohn disease
Treatment phase: Continuing treatment
Manner of administration:Injection
Restriction
Indication: Complex refractory Fistulising Crohn disease
Treatment phase: Subsequent continuing treatment
Manner of administration:Injection
Restriction (Streamlined authority code: 19207)
Indication: Complex refractory Fistulising Crohn disease
Treatment phase: Continuing treatment
